24-Week data show TPN-101 is the first treatment for PSP to reduce NfL levels, a key biomarker of neurodegeneration in tauopathies such as PSP and Alzheimer s disease
New York, USA, Oct. 16, 2023 (GLOBE NEWSWIRE) Frontotemporal Dementia Treatment Drug Market to Showcase Immense Growth During the Study Period (2019–2032) | DelveInsight The overall frontotemporal dementia
NB: this is a summary translation of the press release original drafted in Japanese for the disclosure required in compliance with the TSE regulations. . | May 12, 2023
Right now, there is no cure for amyotrophic lateral sclerosis (ALS) and approved therapies only moderately slow progression of the disease. .